We are on a mission to fix the broken healthcare system and create equitable solutions for care.
Recognized as a global leader in precision health, Stanford Medicine is making major strides in a advancing the entire field. Dr. Michael Snyder has built the most robust precision health ecosystem in the world, with over 100 scientists working at the forefront of precision health innovation.
Stanford is ranked #1 in U.S. News 2019 for genomics, bioinformatics, biological sciences, neuroscience, and biochemistry. Our team of medical innovators lead the field at the intersection of computer science and biology. As healthcare data sources increase, we are entering a new era of precision medicine.
10,000 ft²+
lab space
100+
scientists
$7 billion+
value from company spinouts
“We are passionate about raising the standard of care for everyone. We are creating new systems that make health accessible and affordable for all.”
Michael Snyder, Ph.D.
Chairman & Professor, Department of Genetics
Director, Center for Genomics and Personalized Medicine
DR. MICHAEL SNYDER
In 2009, Snyder was recruited by Stanford University to Chair the Genetics Department and to direct the Center for Genomics and Personalized Medicine. Under his leadership, U.S. News & World Report has ranked Stanford University first or tied for first in Genetics, Genomics and Bioinformatics every year since 2010. For the past decade, Mike has been using longitudinal tracking and measuring everything about human health to predict and prevent disease ahead of time. With over 100 people in his lab, Dr. Snyder is changing the landscape of diabetes, cancer, cardiovascular disease, aging, and mental health by learning how to keep people healthy rather than treat them once they are already sick.
A Brand New Approach to Medicine
Dr. Michael Snyder has pioneered longitudinal personalized multiomic profiling, tracking and integrating millions of pieces of health data over time for an individual. This approach allows us to characterize an individual’s healthy baseline, and when deviations from baseline occur, we can intervene to maintain health. This means early detection and prevention of disease, including cancer, cardiovascular disease, diabetes, and infection.
SCALABLE
Dr. Snyder’s laboratory study was the first to perform a large-scale functional genomics project in any organism, and has developed many technologies in genomics and proteomics.
PERSONALIZED
The fields of personalized health, nutrition, and precision medicine. He was the first to apply personalized health tracking on a large scale.
DETAILED
Dr. Snyder established the first longitudinal detailed ‘omics profiling of humans. We are measuring almost possible outcome for human health, including standard clinical tests, and nearly all of the molecules in blood, urine, stool, saliva, as well as heart rate, sleep, and airborne exposures.
Timeline
Mike’s lab launches the first systems biology approach to analyzing every gene and its function simultaneously (published 1994)
2000
2001
Mike’s lab together with Pat Brown’s lab invents ChIP-Chip for widespread mapping of transcription factor binding regions
2003
2004
2006
2007
Mike’s lab publishes first de novo genome sequencing use NexGen sequencing technology
2008
2009
2010
2011
2017
2018
2019
Mike’s spinout company Q.Bio (based on the Big Data + Longitudinal Profiling Approach) reports initial case studies detecting early stage cancers;
Mike’s lab together with others publishes first omics study of astronauts
2020
Mike launches the Healthcare Innovation Lab to accelerate Precision Health research and development within Stanford Medicine;
Mike’s lab described personalized aging (Ageotypes)
TOTAL VC FUNDING $242,271,345
TEAM & AFFILIATES
Steering Committee
Mike Snyde
Faculty Director
Lab Member and Collaborators
Department of Genetics Stanford Medicine
Department of Genetics Stanford Medicine
The healthcare innovation lab funds highly translational work at Stanford
in a non-linear fashion—allowing for high risk, high impact projects and
fast iteration to bring them to clinic and market. Your gift will fund the
most promising projects and allow for the creativity and flexibility that is
needed to drive paradigm shifting translational research and development.
Become a lab insider.
Sign up for our newsletter and be the first
to hear about new studies in development.
Subscriber Benefits
Subscribers receive pre-print access to our COVID-19 wearables study, research study participation opportunities, investigations to SHIL events, and more!
Connect
COVID-19 Wearables
